The RING ubiquitin E3 RNF114 interacts with A20 and modulates NF-κB activity and T-cell activation

  • Cell Death Dis. 2014 Aug 28;5(8):e1399. doi: 10.1038/cddis.2014.366.
M S Rodriguez  1 ,  I Egaña  2 ,  F Lopitz-Otsoa  2 ,  F Aillet  1 ,  M P Lopez-Mato  3 ,  A Dorronsoro ,  S Lobato-Gil  1 ,  J D Sutherland  2 ,  R Barrio  2 ,  C Trigueros  4 ,  V Lang  1
Affiliations
  • 1. Cancer Unit, Inbiomed, San Sebastian, Gipuzkoa, Spain.
  • 2. CIC bioGUNE, Derio, Bizkaia, Spain.
  • 3. Cytometry and Advanced Optical Microscopy Core Facility, Inbiomed, San Sebastian, Gipuzkoa, Spain.
  • 4. Hematological Diseases, Inbiomed, San Sebastian, Gipuzkoa, Spain.
Abstract

Accurate regulation of nuclear factor-κB (NF-κB) activity is crucial to prevent a variety of disorders including immune and inflammatory diseases. Active NF-κB promotes IκBα and A20 expression, important negative regulatory molecules that control the NF-κB response. In this study, using two-hybrid screening we identify the RING-type zinc-finger protein 114 (RNF114) as an A20-interacting factor. RNF114 interacts with A20 in T cells and modulates A20 ubiquitylation. RNF114 acts as negative regulator of NF-κB-dependent transcription, not only by stabilizing the A20 protein but also IκBα. Importantly, we demonstrate that in T cells, the effect of RNF114 is linked to the modulation of T-cell activation and Apoptosis but is independent of cell cycle regulation. Altogether, our data indicate that RNF114 is a new partner of A2O involved in the regulation of NF-κB activity that contributes to the control of signaling pathways modulating T cell-mediated immune response.